Cita APA (7a ed.)

Caplin, M. E. (2021). Can the peptide receptor radionuclide therapy [177Lu]Lu-DOTA-TATE provide a net benefit for NET patients? Elsevier.

Cita Chicago Style (17a ed.)

Caplin, Martyn E. Can the Peptide Receptor Radionuclide Therapy [177Lu]Lu-DOTA-TATE Provide a Net Benefit for NET patients? Elsevier, 2021.

Cita MLA (8a ed.)

Caplin, Martyn E. Can the Peptide Receptor Radionuclide Therapy [177Lu]Lu-DOTA-TATE Provide a Net Benefit for NET patients? Elsevier, 2021.